Virginia Commonwealth University

VCU Massey Cancer Center

Interactive personal health records increase clinical preventive services

Alex Krist, M.D.

Patients who use an interactive personal health record (IPHR) are almost twice as likely to be up to date with clinical preventive services as those who do not, according to a new study led by Alex Krist, M.D., M.P.H., research member of the Cancer Prevention and Control program at Virginia Commonwealth University Massey Cancer Center.

Continue reading →

Antibodies from rabbits reduce risks associated with unrelated donor stem cell transplantation

Researchers at Virginia Commonwealth University (VCU) Massey Cancer Center‘s Bone Marrow Transplant Program have demonstrated that the use of antibodies derived from rabbits can improve the survival and relapse outcomes of leukemia and myelodysplasia patients receiving a stem cell transplant from an unrelated donor.

Continue reading →

New technology improves detection of prostate cancer cells in a patient’s bloodstream

VCU Massey Cancer Center continues to test new technology by ApoCell, Inc. that can detect circulating tumor cells (CTC) in a patient’s bloodstream. In April, Massey reported on a pilot study of the device in liver cancer patients, and now a new study demonstrates that the device can effectively collect CTCs in patients with metastatic prostate cancer.

Continue reading →

Novel radiation therapy safely treats prostate cancer and lowers the risk of recurrence

A recent phase 2/3 clinical trial has shown that a new combination of radiation therapies developed at Virginia Commonwealth University Massey Cancer Center  escalates radiation doses to safely and effectively treat prostate cancer and lower the risk of recurrence with minimal radiation exposure to nearby healthy tissue and organs.

Continue reading →